Position in OGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$37,167,300
New position
Shares Held
2,745,000
first reported quarter
Ownership
1.05%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#21
of 626 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in OGN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$29
PutShares
1,569
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLAZER CAPITAL, LLC holds $37,167,300 across 1 Drug Manufacturers - General name. OGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
This page
|
2,745,000 | $37,167,300 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,167,300 | 2,745,000 | Shares | Sole | 2026-08-17 | |
| 2026-06-30 | $29 | 1,569 | Put | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||